Comparison of whole blood cytokine immunoassays for rapid, functional immune phenotyping in critically ill patients with sepsis

Anthony S. Bonavia,Abigail Samuelsen,Menglu Liang,Jodi Hanson,Daniel McKeone,Zissis C. Chroneos,E. Scott Halstead

DOI: https://doi.org/10.1186/s40635-023-00556-w

2023-10-15

Intensive Care Medicine Experimental

Abstract:Sepsis is characterized by highly heterogeneous immune responses associated with a spectrum of disease severity. Methods that rapidly and sensitively profile these immune responses can potentially personalize immune-adjuvant therapies for sepsis. We hypothesized that the ELLA microfluidic approach to measure cytokine production from the whole blood of septic and critically ill patients would deliver faster, more precise results than the existing optic-driven ELISpot quantification. We tested our hypothesis by measuring ex vivo - stimulated production of TNF and IFNγ in critically ill and septic patients ( n = 22), critically ill and non-septic patients ( n = 10), and healthy volunteers ( n = 10) through both ELLA and ELISpot immunoassays. Blood samples were subjected to one of three stimulants for 4 h or 18 h durations during days 1, 7–10, and 14 of critical illness. Stimulants for lymphocytes included anti-CD3/anti-CD28 and phorbol 12-myristate 13-acetate (PMA), whereas LPS was used for monocytes. Stimulated TNF and IFNγ concentrations were then associated with 30-day mortality.